Schedule 13G ownership disclosure
REGULUS THERAPEUTICS INC
Security class unavailable · CUSIP: 75915K200
Event date: 2019-05-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,327,801
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-19-003780
- Form type
- SC 13G
- Filer
- Altium Capital Management LLC
- CIK
- CIK 1746382
- Filed
- May 17, 2019
- Reporting period
- May 07, 2019
- Description
- Schedule 13G beneficial ownership